"Effect of Aromatherapy on Neuropathic pain Arising from Diabet"

The Affection of Aromatherapy on Neuropathic Pain and Quality of Life in Diabetic Patients Referring to Diabets Clinics Affiliated to Shiraz University of Medical Science,2019-2020

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191106045352N1

Enrollment

Registered

2020-07-10

Start date

2020-01-21

Completion date

Unknown

Last updated

2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic neuropathy. Drug or chemical induced diabetes mellitus with neurological complications with diabetic neuropathy, unspecified

Interventions

Intervention 1: Intervention group: "First intervention group": Lavender oil (3%) produced in Noorhan company in the knee area down (2.5 cc for each leg) is applied every night before bed for a month.

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Diabetic Patients Ages 18 to 65 years Willingness to participate in research Obtain a score higher than or equal to 4 on the DN4 clinical acceptance questionnaire

Exclusion criteria

Exclusion criteria: Nonconformity the protocol Not willing to continue cooperation Existence of other diseases causing neuropathic pain (trauma, systemic diseases, autoimmune, etc.) having any scars on the legs catching up diabetic foot sensitivity to essential oils catching up coagulation disorders pregnancy

Design outcomes

Primary

Measure	Time frame
The percentage of people with greater than or equal to 4 on the DN4 clinical acceptance questionnaire. Timepoint: Before the intervention, the second week, the fourth week. Method of measurement: DN4 clinical acceptance questionnaire.;Pain Score in Pain Evaluation Criteria (VAS). Timepoint: Before the intervention, the second week, the fourth week. Method of measurement: Pain Assessment Criterion (VAS).;Received score from Persian Quality of Life Questionnaire 36 Questions (Dr. Montazeri). Timepoint: Before the intervention, the second week, the fourth week. Method of measurement: Farsi Quality of Life Questionnaire 36 questions(Dr.Montazeri).	—

Measure

Time frame

The percentage of people with greater than or equal to 4 on the DN4 clinical acceptance questionnaire. Timepoint: Before the intervention, the second week, the fourth week. Method of measurement: DN4 clinical acceptance questionnaire.;Pain Score in Pain Evaluation Criteria (VAS). Timepoint: Before the intervention, the second week, the fourth week. Method of measurement: Pain Assessment Criterion (VAS).;Received score from Persian Quality of Life Questionnaire 36 Questions (Dr. Montazeri). Timepoint: Before the intervention, the second week, the fourth week. Method of measurement: Farsi Quality of Life Questionnaire 36 questions(Dr.Montazeri).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMonireh Rahpeima

Shiraz University of Medical Sciences

m.rahpeima.191372@gmail.com+98 71 5800 9341

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026